Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Axicabtagene ciloleucel for patients with non-hodgkin lymphoma

Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Axicabtagene ciloleucel for patients with non-hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
10 Dec 2017

Data from the CLARITY trial of ibrutinib plus venetoclax

Prof Peter Hillmen - University of Leeds, Leeds, UK
Data from the CLARITY trial of ibrutinib plus venetoclax ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017

Mogamulizumab for cutaneous T- cell lymphoma

Prof Youn Kim - Stanford University, Stanford, CA
Mogamulizumab for cutaneous T- cell lymphoma ( Prof Youn Kim - Stanford University, Stanford, CA )
10 Dec 2017

Phase 1 study of Blu-285 in advanced systemic mastocytosis

Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
Phase 1 study of Blu-285 in advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017

Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial

Prof Peter Hillmen - University of Leeds, Leeds, UK
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017

Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma

Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017

Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study

Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017

New treatments for acute myeloid leukaemia

Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA
New treatments for acute myeloid leukaemia ( Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA )
10 Dec 2017

ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma

Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017

Long term follow up on the ZUMA-1 trial for nHL

Dr Sattva Neelapu - MD Anderson Center, Houston, USA
Long term follow up on the ZUMA-1 trial for nHL ( Dr Sattva Neelapu - MD Anderson Center, Houston, USA )
10 Dec 2017

BLU-285 for advanced systemic mastocytosis

Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
BLU-285 for advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017

Mogamulizumab demonstrates significant improvement in progression free survival for CTCL

Dr Steven Horwitz - Memorial Sloan Kettering Cancer Center, New York, USA
Mogamulizumab demonstrates significant improvement in progression free survival for CTCL ( Dr Steven Horwitz - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation